Acute Treatment of Migraine
- PMID: 31563229
- DOI: 10.1016/j.ncl.2019.07.006
Acute Treatment of Migraine
Abstract
All patients with migraine merit acute treatment, which should optimally achieve a sustained pain-free response. Maximum acute treatment is associated with reduced risk of transformation of episodic to chronic migraine. The American Headache Society published the most recent complete evidence assessment of acute migraine treatments in 2015. Noninvasive neuromodulation represents a new, Food and Drug Administration-approved nonsignificant risk alternative for acute migraine therapy. The future of acute migraine treatment includes new devices and formulations of existing medications, new classes of acute medications, and new noninvasive nonsignificant risk neuromodulation devices, with many anticipated in the next few years.
Keywords: Acute migraine treatment; Ditans; Ergots; Gepants; Migraine; NSAIDs; Neuroleptics; Triptans.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
2022 Taiwan Guidelines for Acute Treatment of Migraine.Acta Neurol Taiwan. 2022 Jun 30;31(2):89-113. Acta Neurol Taiwan. 2022. PMID: 36153693
-
Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.Headache. 2015 Jun;55(6):825-39. doi: 10.1111/head.12556. Epub 2015 Apr 17. Headache. 2015. PMID: 25881857
-
Risk of medication overuse headache across classes of treatments for acute migraine.J Headache Pain. 2016 Dec;17(1):107. doi: 10.1186/s10194-016-0696-8. Epub 2016 Nov 24. J Headache Pain. 2016. PMID: 27882516 Free PMC article. Review.
-
Pharmacokinetics and pharmacodynamics of new acute treatments for migraine.Expert Opin Drug Metab Toxicol. 2019 Mar;15(3):189-198. doi: 10.1080/17425255.2019.1578749. Epub 2019 Feb 12. Expert Opin Drug Metab Toxicol. 2019. PMID: 30714429 Review.
-
Acute Migraine Treatment in Adults.Headache. 2015 Jun;55(6):778-93. doi: 10.1111/head.12550. Epub 2015 Apr 15. Headache. 2015. PMID: 25877672 Review.
Cited by
-
Assessing the reliability and readability of migraine treatment information on Turkish websites.BMC Health Serv Res. 2024 Sep 27;24(1):1124. doi: 10.1186/s12913-024-11599-4. BMC Health Serv Res. 2024. PMID: 39334340 Free PMC article.
-
Clinical Outcome of Nerve Decompression Surgery for Migraine Improves with Nerve Wrap.Plast Reconstr Surg Glob Open. 2021 Oct 22;9(10):e3886. doi: 10.1097/GOX.0000000000003886. eCollection 2021 Oct. Plast Reconstr Surg Glob Open. 2021. PMID: 34703716 Free PMC article.
-
Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center.Neurol Sci. 2022 Sep;43(9):5717-5724. doi: 10.1007/s10072-022-06164-y. Epub 2022 May 27. Neurol Sci. 2022. PMID: 35618934
-
Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.J Manag Care Spec Pharm. 2021 Sep;27(9):1157-1170. doi: 10.18553/jmcp.2021.21060. Epub 2021 May 17. J Manag Care Spec Pharm. 2021. PMID: 33998825 Free PMC article.
-
Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial.BMJ. 2021 Jun 30;374:n1448. doi: 10.1136/bmj.n1448. BMJ. 2021. PMID: 34526307 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
